Status:
COMPLETED
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
Lead Sponsor:
The Republican Research and Practical Center for Epidemiology and Microbiology
Collaborating Sponsors:
Belarusian State Medical University
Conditions:
CMV
Eligibility:
All Genders
18-80 years
Brief Summary
Current study evaluates possible correlations between the content of various cell populations, the genetic material of the virus and antibodies to it in the blood of patients and the risk of thrombosi...
Detailed Description
* evaluate the immune status main indicators that characterize the activation of immune system, immunosuppression and anergy (myeloid suppressor cells, T-regulatory cells, T-cells according to the sta...
Eligibility Criteria
Inclusion
- age 18 - 80 years;
- fever of not clear etiology
- confirmed CMV infection
Exclusion
- HIV infection
- taking hormones, cytostatics;
- drug addiction
- malignant neoplasms over the past 5 years.
- active viral hepatitis or liver cirrhosis;
- immunosuppressive conditions of any etiology
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04392297
Start Date
July 1 2019
End Date
January 31 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Republican Research and Practical Center for Epidemiology and Microbiology
Minsk, Belarus, 220114